Boston Financial Mangement LLC raised its position in shares of CME Group Inc. (NASDAQ:CME) by 2.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 96,244 shares of the financial services provider’s stock after acquiring an additional 2,250 shares during the period. Boston Financial Mangement LLC’s holdings in CME Group were worth $13,058,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Fiduciary Trust Co. bought a new stake in shares of CME Group during the second quarter worth approximately $105,000. Quadrant Capital Group LLC boosted its holdings in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares during the period. San Francisco Sentry Investment Group CA bought a new stake in shares of CME Group during the second quarter worth approximately $129,000. Whittier Trust Co. boosted its holdings in shares of CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 27 shares during the period. Finally, People s United Financial Inc. boosted its holdings in shares of CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares during the period. Institutional investors own 82.79% of the company’s stock.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. During the same period last year, the firm earned $1.05 EPS. CME Group’s revenue for the quarter was up 5.8% on a year-over-year basis.
In other CME Group news, President Bryan T. Durkin sold 9,200 shares of the firm’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total value of $1,151,196.00. Following the completion of the transaction, the president now directly owns 70,938 shares of the company’s stock, valued at approximately $8,876,471.94. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Julie Holzrichter sold 11,915 shares of the firm’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $125.67, for a total transaction of $1,497,358.05. Following the completion of the transaction, the chief operating officer now directly owns 43,657 shares of the company’s stock, valued at $5,486,375.19. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,479 shares of company stock valued at $3,498,921. Insiders own 0.57% of the company’s stock.
A number of equities research analysts have recently issued reports on CME shares. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 27th. Barclays PLC boosted their price objective on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Jefferies Group LLC restated a “buy” rating and set a $128.00 price objective on shares of CME Group in a report on Monday, July 10th. UBS AG restated a “buy” rating and set a $135.00 price objective (up previously from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Finally, Royal Bank Of Canada boosted their price objective on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $138.89.
WARNING: “CME Group Inc. (CME) Shares Bought by Boston Financial Mangement LLC” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.com-unik.info/2017/11/02/cme-group-inc-cme-shares-bought-by-boston-financial-mangement-llc.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.